CRISPR-Cas9 Genome Editing Technology

TL;DR

The CRISPR-Cas9 system is a genome editing technology that allows for precise manipulation of genetic information, with various applications in fields like cancer immunotherapy and disease prevention.

Transcript

We’ve examined a handful of biotechnology concepts  in previous tutorials, but now it’s time to   introduce what is undoubtedly the most promising  technique in biotechnology of the past decade. The   CRISPR-Cas9 system represents genome editing  technology that has revolutionized molecular   biology, due to its precise and site-specific gene  edit... Read More

Key Insights

• 🧬 CRISPR-Cas9 system is a revolutionary genome editing technology that offers precise gene editing capabilities in organisms, allowing for unprecedented control in manipulating genetic information.
• 🦠 CRISPR was first discovered in prokaryotes and serves as a defense mechanism against viral DNA, bacteriophages, and plasmids.
• 🔬 Jennifer Doudna and Emmanuelle Charpentier proposed using CRISPR as a programmable toolkit for genome editing in humans and animals, leading to the Nobel prize in chemistry in 2020.
• 🧬 Genome editing using CRISPR can be achieved by synthesizing single guide RNA (sgRNA) that complexes with Cas9 protein to cleave DNA at desired locations.
• 💉 CRISPR has potential applications in cancer immunotherapy, modifying immune T cells to recognize and kill cancer cells more efficiently.
• 💊 It can also be used in the therapeutic management of AIDS, targeting the proviral latent reservoir that conventional therapies fail to address.
• 🧪 CRISPR is valuable in developing assays to detect SARS-CoV-2 infection and has vast potential in disease cures and prevention of gene-linked diseases.
• 🌱 CRISPR technology can be used to improve plant traits, enhance disease resistance, and increase crop yield.

Questions & Answers

Q: How does the CRISPR-Cas9 system work in prokaryotic organisms as a defense mechanism?

The CRISPR-Cas9 system in prokaryotes involves the incorporation of viral DNA sequences (spacers) into the CRISPR locus, forming a memory of past viral infections. When encountering a viral DNA with a sequence complementary to the CRISPR RNA (crRNA), the Cas9 protein cleaves the virus DNA, neutralizing the infection.

Q: What is the role of the Cas9 protein in the CRISPR-Cas9 system?

The Cas9 protein is a nuclease enzyme capable of cleaving DNA at specific nucleotide linkages. In the CRISPR-Cas9 system, it binds to the complex formed by the crRNA, tracrRNA, and spacer sequences, and it cleaves the DNA at a precise location determined by the crRNA sequence, effectively disabling the targeted gene or viral DNA.

Q: What are some potential applications of the CRISPR-Cas9 system?

The CRISPR-Cas9 system has various applications, including genetic screens, cancer immunotherapy, AIDS management, SARS-CoV-2 detection, genome editing in human embryos, genetic editing of somatic cells, and genome editing in plants. It has the potential to cure diseases, prevent the inheritance of gene-linked diseases, and improve crop yield and characteristics.

Q: What are the two routes of DNA repair after the Cas9 protein cleaves the DNA?

After the Cas9 protein cleaves the target DNA, the repair can occur through homology-directed repair (HDR) or non-homologous end joining (NHEJ). HDR uses a homologous DNA template to guide repair and maintain uniformity in the size of the resulting DNA, while NHEJ repairs without a homologous template, sometimes resulting in indels (insertions or deletions) and non-uniformity in size.

Summary & Key Takeaways

• The CRISPR-Cas9 system was first discovered in bacteria and archaea as a defense mechanism against viral DNA, but it has since been applied to genome editing in eukaryotic species.

• The system involves the use of CRISPR arrays, CRISPR RNA (crRNA), tracrRNA, and the Cas9 protein to target and cleave specific DNA sequences.

• CRISPR-Cas9 has a wide range of potential applications, including genetic screens, cancer immunotherapy, AIDS management, detection of SARS-CoV-2 infection, and genome editing in plants.